Jul 29, 2021 / 08:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Ligand Pharmaceuticals' Second Quarter Earnings Call. (Operator Instructions)
I would now like to hand the conference over to your first speaker today, the Head of Investor Relations, Mr. Simon Latimer. Please go ahead, sir.
Simon Latimer;Corporate Development - Strategy, & Investor Relations Manager,
Thank you. Welcome to Ligand's Second Quarter 2021 Financial Results and Business Update Conference Call. Our speakers for today's call are at separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will use non-GAAP financial measures, and some of our statements will be forward-looking, including those related to our financial condition, results of operations, financial guidance, and the impact of the COVID-19 pandemic. Additional information concerning risk factors and other matters concerning Ligand can be found in our earnings press release and our periodic filings with the SEC. We undertake no obligation to revise
Q2 2021 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers